Melissa Runsten

Paul Rubin

Melissa Runsten is a corporate associate and a member of the Healthcare Group. Her practice focuses on FDA/FTC regulatory matters, including complex advertising and promotion-related issues. Ms. Runsten also handles disputes before the FTC and NAD, and false advertising lawsuits under Section 43(a) of the Lanham Act.

For more information or to contact Melissa, please visit her Firm Profile Page.

Posts by Melissa Runsten

Rule Requiring Prescription Drug Price Disclosures in TV Ads Will Create Complex Lanham Act Enforcement Issues and First Amendment Implications

A Final Rule issued by the Centers for Medicare and Medicaid Services (CMS) on May 8 (the “Final Rule”) that requires direct-to-consumer (DTC) television advertisements for a prescription …